Anticardiolipin antibodies: a study in cerebral venous thrombosis

Abstract

The findings suggest that anticardiolipin antibodies are a risk marker for cerebral venous thrombosis. Further studies on a larger group of patients are needed to establish the role of aCL in the pathogenesis of CVT.